Market Tracker

05/27 2:30pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

0.60
BATS BZX Real-Time Price
As of 2:07pm ET
 +0.03 / +5.26%
Today’s Change
0.53
Today|||52-Week Range
8.75
-80.58%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close0.57
Today’s open0.60
Day’s range0.59 - 0.61
Volume3,656
Average volume (3 months)160,189
Market cap$14.9M
Dividend yield--
Data as of 2:07pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)+33.19%
Earnings growth (next 5 years)--
Revenue growth (last year)+17,425.00%
P/E ratioNM
Price/Sales100.27
Price/Book0.38

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...-0.03-6.69%
GNVCGenVec Inc-0.04-5.78%
ACSTAcasti Pharma Inc+0.01+0.67%
RTTRRitter Pharmaceutica...0.000.00%
Data as of 2:06pm ET, 05/27/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$701.0K
Annual profit (last year)-$52.2M
Net profit margin-7,444.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Independent Director
Scott M. Rocklage
President &
Chief Operating Officer
Michael Wyand
Corporate headquarters
Boston, Massachusetts

Forecasts